Elliot Marseille

Summary

Affiliation: University of Virginia Health System
Country: USA

Publications

  1. ncbi HIV prevention before HAART in sub-Saharan Africa
    Elliot Marseille
    Institute for Health Policy Studies, Center for AIDS Prevention Studies, and AIDS Research Institute, University of California, San Francisco, Box 0936, San Francisco CA 94143, USA
    Lancet 359:1851-6. 2002
  2. pmc HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
  3. pmc Cost-effectiveness of male circumcision for HIV prevention in a South African setting
    James G Kahn
    Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America
    PLoS Med 3:e517. 2006
  4. doi Gestational diabetes mellitus: results from a survey of country prevalence and practices
    Aliya Jiwani
    Health Strategies International, San Francisco, USA
    J Matern Fetal Neonatal Med 25:600-10. 2012
  5. ncbi Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry
    Valerie J Flaherman
    Department of Pediatrics, University of California San Francisco, 3333 California St, San Francisco, CA 94118, USA
    Pediatrics 120:90-9. 2007
  6. pmc CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
    James G Kahn
    Philip R Lee Institute for Health Policy Studies and Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    BMJ 343:d6884. 2011
  7. ncbi A saga in international HIV policy modeling: preventing mother-to-child HIV transmission
    James G Kahn
    Institute for Health Policy Studies, University of California, San Francisco, USA
    J Policy Anal Manage 21:499-505. 2002
  8. ncbi The cost of a rapid-test VCT clinic in South Africa
    Coline E McConnel
    Institute for Health Policy Studies and AIDS Research Institute, University of California, San Francisco, USA
    S Afr Med J 95:968-71. 2005
  9. ncbi The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda
    Elliot Marseille
    Health Strategies International, Orinda, California 94563, USA
    AIDS 20:907-14. 2006
  10. pmc Changing cost of HIV interventions in the context of scaling-up in India
    Lalit Dandona
    George Institute for International Health India, Hyderabad, India
    AIDS 22:S43-9. 2008

Detail Information

Publications19

  1. ncbi HIV prevention before HAART in sub-Saharan Africa
    Elliot Marseille
    Institute for Health Policy Studies, Center for AIDS Prevention Studies, and AIDS Research Institute, University of California, San Francisco, Box 0936, San Francisco CA 94143, USA
    Lancet 359:1851-6. 2002
    ..The findings and recommendations of this analysis pertain to the phasing in of additional HIV-related activities during the current period of improved but inadequate funding...
  2. pmc HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
    ..Information on the relationship between scale and unit costs is critical to project the cost of global HIV prevention efforts and to allocate prevention resources efficiently...
  3. pmc Cost-effectiveness of male circumcision for HIV prevention in a South African setting
    James G Kahn
    Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America
    PLoS Med 3:e517. 2006
    ..The objective of this study is to present the first cost-effectiveness analysis of the use of MC as an intervention to reduce the spread of HIV in sub-Saharan Africa...
  4. doi Gestational diabetes mellitus: results from a survey of country prevalence and practices
    Aliya Jiwani
    Health Strategies International, San Francisco, USA
    J Matern Fetal Neonatal Med 25:600-10. 2012
    ..However, the global burden of GDM and the existing responses are not fully understood. We aimed to assess country prevalence and to summarize practices related to GDM screening and management...
  5. ncbi Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry
    Valerie J Flaherman
    Department of Pediatrics, University of California San Francisco, 3333 California St, San Francisco, CA 94118, USA
    Pediatrics 120:90-9. 2007
    ..We undertook a decision analysis to evaluate the economic and health effects and incremental cost-effectiveness of using targeted tuberculin skin testing, compared with universal screening or no screening, before kindergarten...
  6. pmc CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
    James G Kahn
    Philip R Lee Institute for Health Policy Studies and Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    BMJ 343:d6884. 2011
    ..To examine the cost and cost effectiveness of quarterly CD4 cell count and viral load monitoring among patients taking antiretroviral therapy (ART)...
  7. ncbi A saga in international HIV policy modeling: preventing mother-to-child HIV transmission
    James G Kahn
    Institute for Health Policy Studies, University of California, San Francisco, USA
    J Policy Anal Manage 21:499-505. 2002
  8. ncbi The cost of a rapid-test VCT clinic in South Africa
    Coline E McConnel
    Institute for Health Policy Studies and AIDS Research Institute, University of California, San Francisco, USA
    S Afr Med J 95:968-71. 2005
    ..Demand for HIV voluntary counselling and testing (VCT) will increase as HIV prevention and treatment scale up in South Africa. Understanding the cost of delivering VCT will inform funding decisions...
  9. ncbi The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda
    Elliot Marseille
    Health Strategies International, Orinda, California 94563, USA
    AIDS 20:907-14. 2006
    ..The objective of this study was to determine the financial incentives that companies have to treat HIV-infected employees, in a health care services company in Kampala, Uganda...
  10. pmc Changing cost of HIV interventions in the context of scaling-up in India
    Lalit Dandona
    George Institute for International Health India, Hyderabad, India
    AIDS 22:S43-9. 2008
    ..A rapid scaling up of HIV interventions in India is anticipated, but systematic information on how costs of HIV interventions change over time and programme scale is not available to inform planning...
  11. pmc Public health. Reassessing HIV prevention
    Malcolm Potts
    School of Public Health, University of California at Berkeley, Berkeley, CA 94720, USA
    Science 320:749-50. 2008
  12. pmc Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India
    Lalit Dandona
    George Institute for International Health India, Hyderabad, India
    BMC Health Serv Res 8:26. 2008
    ..PMTCT services are mostly provided at public sector government hospitals in India. Systematic data on the cost and efficiency of providing PMTCT services in India are not available readily for further planning...
  13. pmc Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project
    Elliot Marseille
    Health Serv Res 39:1993-2012. 2004
    ..To develop data collection methods suitable to obtain data to assess the costs, cost-efficiency, and cost-effectiveness of eight types of HIV prevention programs in five countries...
  14. pmc HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency
    Lalit Dandona
    Health Studies Area, Centre for Human Development, Administrative Staff College of India, Hyderabad, India
    BMC Public Health 5:98. 2005
    ..Systematic data on the outputs, cost and efficiency for HIV prevention programmes for female sex workers in India are not readily available to understand programme functioning and guide efficient use of resources...
  15. ncbi Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda
    Christian Pitter
    Elizabeth Glaser Pediatric AIDS Foundation, 1140 Connecticut Avenue NW, Washington, DC 20036, USA
    J Acquir Immune Defic Syndr 44:336-43. 2007
    ..We assessed the cost-effectiveness of cotrimoxazole prophylaxis for persons living with HIV in rural Uganda...
  16. pmc Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India
    Lalit Dandona
    Health Studies Area, Centre for Human Development, Administrative Staff College of India, Hyderabad, India
    BMC Health Serv Res 5:69. 2005
    ..Data on the cost and efficiency of providing STI services in India are not available to help guide efficient use of public resources for these services...
  17. pmc Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants
    Travis C Porco
    California Department of Health Services, Tuberculosis Control Branch, 850 Marina Bay Parkway, Building P, Second Floor, Richmond, CA 94804, USA
    BMC Public Health 6:157. 2006
    ..S. is not well understood. We determined the cost-effectiveness of domestic follow-up of immigrants identified as tuberculosis suspects through overseas screening...
  18. ncbi Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda
    Ram K Shrestha
    Global AIDS Program, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 20333, USA
    Am J Trop Med Hyg 74:884-90. 2006
    ..SWS is an effective intervention whose cost-effectiveness is sensitive to diarrhea-related mortality, diarrhea incidence, and effective clinical management...
  19. ncbi Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options
    Mead Over
    World Bank, Washington, DC 20433, USA
    Sex Transm Dis 33:S145-52. 2006
    ..The objective of this study is to assess the costs, cost-effectiveness, and HIV epidemic impact of 3 antiretroviral therapy (ART) policy options...